CytoViva

CytoViva is a privately held scientific imaging and instrumentation company headquartered at Auburn Research Park in Auburn, Alabama. Its business centers on optical microscopy and hyperspectral imaging technologies intended to help researchers observe, identify, and characterize nanoscale materials and biological structures. The company serves research areas that include nanomaterials, biomedicine, pathogen detection, general biology, plant pathology, materials science, and live-cell imaging. The core technology behind CytoViva was invented by Vitaly Vodyanoy, a physiology professor and director of the Biosensor Laboratory at Auburn University. CytoViva commercialized the technology in 2005. The company’s illumination technology subsequently received United States patents in 2009, including patents numbered 7,542,203 and 7,564,623. Rather than relying only on conventional bright-field or dark-field microscopy, the system uses an enhanced darkfield illumination design intended to improve the visibility of nanoscale objects that can be difficult to observe with standard optical methods. CytoViva’s enhanced darkfield system replaces a conventional microscope condenser with an optical assembly using oblique-angle, pre-aligned Köhler illumination. According to the company’s described technology, this configuration can produce substantially higher signal-to-noise images of nanoscale sample elements than standard darkfield microscopy. The approach is designed to allow direct optical observation of particles and structures without necessarily requiring fluorescent labeling, depending on the sample and research objective. In 2008, CytoViva introduced hyperspectral imaging as an integrated capability for its microscopy platform. Hyperspectral microscopy adds spectral information to ordinary spatial imaging by generating spectral image files for analysis. Researchers can use the resulting data to distinguish and map materials according to their spectral fingerprints. Potential targets include nanoparticles, pathogens, subcellular materials, composite constituents, and other nanoscale structures. Analysis may include material mapping, mean-spectrum characterization, and comparison of related samples. The company also offers a dual-mode fluorescence capability that combines fluorescence excitation with full-spectrum transmitted light. This is intended to support real-time observation of fluorescent and non-fluorescent elements in the same sample. Together, the enhanced-darkfield, fluorescence, hyperspectral, and software components form an integrated research platform rather than a conventional consumer microscope product line. Reported applications include mapping silver and gold nanoparticles in cells, tissue, or composite matrices; characterizing drug payloads and functional groups associated with nanoparticles; confirming carbon nanotubes in biological samples; detecting airborne nanomaterials; identifying liposomes used in drug delivery; mapping quantum dots and fluorescently tagged particles; detecting bacteria, viruses, and other pathogens; studying plant disease; characterizing subcellular structures; and imaging living cells. CytoViva distributes its technology internationally through partners. The company reported that more than 300 research laboratories worldwide were using its technology by 2016. Publicly available reference material does not establish a complete current customer count, ownership structure, executive roster, financial profile, or a definitive product-launch chronology beyond the development and commercialization milestones described above. CytoViva is therefore best characterized as a specialized research-instrumentation brand focused on optical methods for nanoscale and biological imaging.

CytoViva’s technology originated in academic research at Auburn University. The underlying optical method was invented by Vitaly Vodyanoy, who was associated with Auburn University as a physiology professor and director of its Biosensor Laboratory. The technology was developed around the problem of making nanoscale materials and biological structures more visible through optical microscopy, particularly where ordinary microscopy methods provide insufficient contrast or require additional labeling. CytoViva commercialized the core technology in 2005, transforming the university-related research platform into a commercial scientific-imaging business. Its initial proposition was based on enhanced darkfield illumination. The system replaces the standard microscope condenser with a specialized optical assembly using oblique-angle and pre-aligned Köhler illumination. This arrangement is designed to improve the signal-to-noise ratio of images containing nanoscale sample elements and to make those elements directly observable through an optical microscope. The illumination technology was protected by United States patents issued in 2009, including U.S. Patent No. 7,542,203 and U.S. Patent No. 7,564,623. These patents represented an important step in formalizing the technical foundation of the company’s microscopy platform. CytoViva subsequently expanded beyond illumination hardware by integrating spectral imaging capabilities with its optical microscopy technology. In 2008, the company introduced hyperspectral imaging as an integrated solution. Hyperspectral imaging records spectral information across image pixels, allowing researchers to distinguish materials by their spectral characteristics as well as their physical location. Within CytoViva’s microscopy environment, this capability can be used to locate and characterize nanoparticles, pathogens, subcellular structures, and constituents of complex composites. Associated analysis tools support spectral mapping, mean-spectrum analysis, and comparisons between materials or samples. CytoViva’s platform also incorporated a dual-mode fluorescence module. The module uses a transmitted-light fluorescence technique that combines fluorescence excitation with full-spectrum light. Its purpose is to permit concurrent observation of fluorescent and non-fluorescent sample elements, which can be useful when researchers need to compare tagged structures with surrounding material or observe dynamic biological samples. The resulting product ecosystem combines optical illumination, microscopy, hyperspectral acquisition, fluorescence, and software analysis. Applications described for the technology span nanomedicine, drug-delivery research, materials characterization, environmental and occupational nanomaterial studies, pathogen research, plant pathology, cell biology, and live-cell imaging. Examples include mapping metallic nanoparticles in tissue, identifying liposomes, characterizing quantum dots, detecting carbon nanotubes, and distinguishing bacteria or viruses. CytoViva is headquartered in Auburn, Alabama, at Auburn Research Park, and operates with distribution partners outside the United States. Reference material stated that more than 300 research laboratories worldwide used CytoViva technology as of 2016. Public sources supplied for this dossier do not provide a verified founding year separate from the 2005 commercialization date, a current executive list, ownership information, financial results, or a detailed record of later product generations. The company’s documented history therefore remains primarily a technology-commercialization history: academic invention, commercial launch, patent protection, integration of hyperspectral imaging, and expansion into a broad set of nanoscale and biological research applications.

• 2016

  Reported adoption by more than 300 laboratories

  [1]CytoVivaen.wikipedia.org

  Reference material reported that more than 300 research laboratories worldwide were using CytoViva technology by this year.

• 2009

  U.S. patents issued for illumination optics

  [1]CytoVivaen.wikipedia.org

  Patents numbered 7,542,203 and 7,564,623 were issued for aspects of the company’s enhanced-darkfield illumination optics.

• 2008

  Hyperspectral imaging integration

  [1]CytoVivaen.wikipedia.org

  The company introduced hyperspectral imaging as an integrated capability alongside its enhanced-darkfield optical microscopy platform.

• 2005

  Commercialization of the core microscopy technology

  [1]CytoVivaen.wikipedia.org

  CytoViva commercialized the optical technology developed from research associated with Auburn University and the Biosensor Laboratory.

A specialized scientific-instrumentation company focused on label-free or complementary optical observation, spectral characterization, and mapping of nanoscale materials and biological structures.

• Optical microscopy component

  Enhanced Darkfield Illumination System

  CytoViva’s patented enhanced-darkfield system replaces a standard microscope condenser with oblique-angle, pre-aligned Köhler illumination. The design is intended to increase the signal-to-noise ratio of optical images containing nanoscale materials and to support direct observation of particles and structures that may be difficult to resolve using ordinary darkfield methods. It is used as the optical foundation for applications involving nanoparticles, pathogens, subcellular materials, and composite samples.

• Hyperspectral imaging system · 2008

  Hyperspectral Microscope System

  This system integrates hyperspectral imaging with optical microscopy to produce image files containing both spatial and spectral information. Researchers can analyze the spectral fingerprints of materials and map their locations within a sample. Described applications include identifying nanoparticles, pathogens, subcellular structures, and constituents of composites, as well as comparing the spectral characteristics of related materials.

• Fluorescence microscopy module

  Dual Mode Fluorescence Module

  The dual-mode fluorescence module combines fluorescence excitation with full-spectrum transmitted light. Its purpose is to enable real-time observation of fluorescent and non-fluorescent elements in the same sample. This capability can complement enhanced-darkfield and hyperspectral measurements in biological, nanomaterial, and live-cell studies where tagged and untagged structures need to be viewed together.

• Scientific imaging software

  Image-analysis software

  CytoViva’s imaging workflow includes analysis functions for working with hyperspectral image files. The software can support spectral mapping, identification of sample elements according to their spectral signatures, mean spectral analysis, and comparison of materials or samples. These functions are intended to turn microscopy observations into spatially resolved material-characterization data.

1. 1CytoVivaen.wikipedia.org
2. 2CytoViva official websitecytoviva.com